These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 9134173
1. Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Adkins D, Goodgold H, Hendershott L, Johnston M, Cravens D, Spitzer G. Bone Marrow Transplant; 1997 Apr; 19(8):809-12. PubMed ID: 9134173 [Abstract] [Full Text] [Related]
2. Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation. Adkins DR, Goodnough LT, Shenoy S, Brown R, Moellering J, Khoury H, Vij R, DiPersio J. Blood; 2000 Jun 01; 95(11):3605-12. PubMed ID: 10828051 [Abstract] [Full Text] [Related]
3. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts. Adkins D, Spitzer G, Johnston M, Velasquez W, Dunphy F, Petruska P. Transfusion; 1997 Jul 01; 37(7):737-48. PubMed ID: 9225939 [Abstract] [Full Text] [Related]
12. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Lonial S, Akhtari M, Kaufman J, Torre C, Lechowicz MJ, Flowers C, Sinha R, Khoury HJ, Langston AA, Waller EK. Biol Blood Marrow Transplant; 2013 Mar 01; 19(3):460-7. PubMed ID: 23201472 [Abstract] [Full Text] [Related]
13. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F. J Clin Oncol; 2004 Feb 01; 22(3):416-23. PubMed ID: 14691124 [Abstract] [Full Text] [Related]
17. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Price TH, Bowden RA, Boeckh M, Bux J, Nelson K, Liles WC, Dale DC. Blood; 2000 Jun 01; 95(11):3302-9. PubMed ID: 10828009 [Abstract] [Full Text] [Related]
18. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases]. Chen Y, Huang X, Xu L, Liu D, Zhang Y, Ren H, Guo N, Lu D. Zhonghua Yi Xue Za Zhi; 2002 Oct 10; 82(19):1306-9. PubMed ID: 12509932 [Abstract] [Full Text] [Related]
19. Collection of two consecutive neutrophil concentrates for transfusion from donors mobilized with glycosylated granulocyte-CSF plus dexamethasone. Heuft HG, Goudeva L, Schwella N, Blasczyk R. Transfusion; 2004 May 10; 44(5):750-7. PubMed ID: 15104658 [Abstract] [Full Text] [Related]
20. Technical and safety aspects of blood and marrow transplantation using G-CSF mobilized family donors. Kadar JG, Arseniev L, Schnitger K, Südmeier I, Zaki M, Battmer K, Jacobs R, Diedrich H, Poliwoda H, Stangel W, Link H. Transfus Sci; 1996 Dec 10; 17(4):611-8. PubMed ID: 10168561 [Abstract] [Full Text] [Related] Page: [Next] [New Search]